Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ALZHEIMER'S INSTITUTE OF AMERICA, INC. v. AVID RADIOPHARMACEUTICALS et al
Case Number:
2:10-cv-06908
Court:
Nature of Suit:
Judge:
Firms
- Cohen Seglias
- Finnegan
- Fox Rothschild
- Greenberg Traurig
- Hangley Aronchick
- Panitch Schwarze
- Stradley Ronon
- Troutman Pepper
Companies
Sectors & Industries:
-
August 17, 2016
Eli Lilly Subsidiary Gets $3.9M In Fees Under Octane Ruling
A Pennsylvania federal judge Wednesday approved a special master's recommendation of $3.9 million in fees to Eli Lilly and Co. subsidiary Avid Radiopharmaceuticals for its expenses defending a bad-faith patent suit by Alzheimer's Institute of America Inc. deemed "exceptional" under the Octane Fitness decision.
-
April 01, 2015
Penn Wins Atty Fees Under Octane In Alzheimer's Patent Suit
Citing Octane Fitness, a Pennsylvania federal judge granted the University of Pennsylvania attorneys' fees in a patent suit in which he found that Alzheimer's Institute of America Inc. did not own the patent it asserted against the university, saying Monday that AIA's conduct constituted bad faith.
-
April 16, 2013
Alzheimer's Institute Seeks New Trial In UPenn Patent Row
The Alzheimer's Institute of America Inc. on Tuesday asked a Pennsylvania federal judge to overturn a jury ruling that the University of Pennsylvania and an offshoot did not infringe patents covering Alzheimer's disease detection, arguing that it had been assigned the patents by the sole inventor of the technology.
-
September 01, 2011
Jury To Rule On Standing In UPenn Alzheimer's IP Row
A Pennsylvania federal judge held Wednesday that a suit accusing the University of Pennsylvania and offshoot Avid Radiopharmaceuticals Inc. of infringing patents covering Alzheimer's disease detection must go to trial over whether the plaintiff, Alzheimer's Institute of America Inc., has standing.
-
November 29, 2010
Alzheimer's Group Hits UPenn, Avid With Patent Suit
Alzheimer's Institute of America Inc. is alleging the University of Pennsylvania and its offshoot Avid Radiopharmaceuticals Inc. infringed two patents when they developed leading-edge technology for detecting Alzheimer's disease.